Price movement over the last 24 hours
Align Technology, Inc. vs United States Brent Oil Fund LP — how do they compare? Align Technology, Inc. trades at $173.86 (market cap $13.27B), while United States Brent Oil Fund LP trades at $43.94. Which is the better fit depends on your goals.
| ALGN | BNO | |
|---|---|---|
Market Cap | $13.27B | — |
Sector | Health | Commodities - Energy |
52-Week High | $207.19 | $60.13 |
52-Week Low | $124.88 | $27.20 |
Enterprise Value | $12.32B | — |
Signals from Pluang's Aura AI — not financial advice
ALGN trades at $185.22, up 0.38% today, with a bullish technical signal and strong analyst consensus. The stock has consistently beaten earnings estimates in recent quarters, with Q2 2026 results expected soon. Revenue remains stable around $4.0B, supported by a 67.57% gross margin and positive cash flow trends. Recent news highlights global expansion and product innovation, including a new manufacturing facility in India.
Outlook is positive with a $220.75 consensus price target, though risks include regulatory scrutiny from the European Commission and competitive pressures. The stock's valuation at a P/E of 31.65 reflects growth expectations, but investors should monitor execution on international growth and demand stability in North America.
BNO trades at $39.94, up 0.68% on the day, amid a bearish technical backdrop with moving averages signaling caution and oscillators neutral. Recent news highlights oil price volatility driven by Middle East tensions and supply disruptions, though fundamental financial ratios are unavailable. The stock faces resistance near $40 with support at $39.
The outlook remains clouded by geopolitical risks and oil market volatility, with limited fundamental data. Upside depends on sustained oil price recovery, but downside risks from supply surges or demand weakness persist. Investors should weigh technical bearishness against external catalysts.
Trailing returns across standard periods
Align is the leading manufacturer of clear dental aligners globally, having pioneered the technology with the introduction of its Invisalign branded aligners in 1998. Since then, Invisalign has become a household name, having treated over 10 million patients with malocclusion (misaligned teeth) through orthodontist and dentist-guided treatment plans. The company maintains dominant market share of clear aligners, despite the introduction of direct-to-consumer competitors upon the expiration of key patents that began in 2017. Align also manufactures intraoral scanners (iTero), used for orthodontic treatment and restorative dental procedures (digital models for crowns, veneers, and implants).
Read more on ALGN →BNO is a commodity ETF that tracks the daily price of Brent crude oil futures. It provides exposure to the international oil benchmark, which often trades at a premium to the U.S. WTI benchmark, and is primarily used for short-term trading due to roll costs.
Read more on BNO →